Variantyx | A provider of genomic diagnostic solutions

NGS in Medical Genetics

Thanks to all who participated in the recent NGS in Medical Genetics conference held in Sudzal, Russia!

We appreciated the opportunity to raise awareness of using clinical WGS to detect small sequence changes, structural variants, short tandem repeats and mitochondrial variants among so many individuals dedicated to providing the best diagnostics for their patients.

NGS in Medical Genetics

Thanks to all who participated in the recent conference held in Sudzal, Russia!
In silico panels: An effective tool for performing targeted, outcome-driven analyses of WGS data

March 28, 2018

In silico panel technology enables labs to benefit from WGS’s superior coverage while retaining the ability to independently analyze discrete slices of sequenced DNA ranging in size from a single gene to tens of thousands of genes.

The genes to be covered by an in silico panel are identified in the same way as the genes to be covered by a traditional panel ...

In silico panels: An effective tool for performing targeted, outcome-driven analyses of WGS data

In silico panel technology enables labs to benefit ...

READ MORE
A clinically validated whole genome pipeline for structural variant detection and analysis

On Demand Webinar

Many benefits are inherent in whole genome sequencing (WGS) technology, including unique opportunities for detection of structural variants. Yet such analyses have generally not made their way into clinical practice.

Listen in as we describe the clinically validated WGS pipeline that we have developed for highly specific and sensitive detection of structural variants. We will discuss the combined use of breakpoint analysis, read depth ...

A clinically validated whole genome pipeline for structural variant detection and analysis

On Demand Webinar

WATCH NOW
The Evolving Standard of Genomic Care

February 14, 2018

The dropping cost of whole genome sequencing (WGS) coupled with the technology’s strengths is driving the next evolutionary step forward in the standard of genetic care for rare disorders. Shortening the diagnostic journey for monogenic disorders, as well as multifactorial inherited disorders like developmental delay.

Read our three-part series that charts the evolution to a WGS diagnostic path and download the accompanying infographic.

The Evolving Standard of Genomic Care

Read our three-part series that charts the evolution to a WGS diagnostic path ...

READ MORE
Exomes are a Transition Test

December 6, 2017

Front Line Genomics recently interviewed Variantyx CEO Haim Neerman at the American Society of Human Genetics conference in Orlando, Florida, where they discussed why whole genome sequencing is the future of genomic diagnostic testing.

Read the full interview ...

Exomes are a Transition Test

Front Line Genomics recently interviewed Variantyx CEO Haim Neerman at the ASHG conference ...

READ INTERVIEW

Revolutionizing genomic medicine with advanced diagnostic products and services

Revolutionizing genomic medicine with advanced diagnostic products and services

Labs

Clinicians

Individuals

News & Events